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We read the recent article by (Mokuolu et al. 2009) with keen interest and would like to congratulate them for a job well done.
However, we would like to raise a few points relating to the limitations of the study.
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properly cited.
Antimalarial use in pregnancy is an important determinant
of the level of malaria parasitaemia at delivery but Mokuolu
et al. [1], like the other workers from Nigeria and other
African countries [2–4], did not assess the eﬀects of anti-
malarial chemoprophylaxis used during pregnancy on the
levels of malaria parasitaemia at parturition. A national
guideline for preventing malaria in pregnancy may not
have existed in Nigeria in 2003 and 2004 when Mokuolu
et al. performed their study; the guidelines of the World
Health Organization (WHO) was in existence and was well
known to many of the obstetricians in Nigeria [4]. Onah
et al. [4] reported that 86% of the obstetricians surveyed
at the annual conference of the Society of Obstetrics and
Gynaecology of Nigeria (SOGON) in 2001 oﬀered chemo-
prophylaxistotheirpatients.Thechemoprophylaxisincludes
chloroquine, pyrimethamine, proguanil, and sulphadoxine-
pyrimethamine. Similarly, a study conducted by Falade et al.
[5] in 2003 and 2004, about the same time Mokuolu et al.
did their study, showed that 85.5% of pregnant women
used some form of antimalarial prophylaxis, sulphadoxine-
pyrimethamine being the most frequently used drug. Self-
medication is very rampant in Nigeria and antimalarials,
especially sulphadoxine-pyrimethamine, being one of the
drugs most frequently self-medicated [6]. Pregnant women
may practice self-medication of antimalarials, moreso when
antimalarials are categorised as over-the-counter drugs.
Therefore, it is very likely that Mokuolu’s patients had
used some form of antimalarials prior to their evaluation
and may not have volunteered such history if their anti-
malarial drug history was focused only on chemoprophy-
laxis.
The authors claimed that they took speciﬁc note of
those patients who used preventive antimalarial drugs, yet
they did not provide the proportion of such patients.
These patients are likely to procure the drug from the
community pharmacies and are at risk of using counterfeit
and adulterated antimalarials which are very abundant in
Nigeria [7]. In the study of Tako et al. [8], 76.3% of their
patients had used one form of antimalarial chemoprophy-
laxis, yet 21.4% of the patients had malaria parasitaemia
at delivery. The failure rate was attributed to resistance
t ot h ed r u g so rt ol a c ko fe ﬃcacy. Considering the risk
of resistance and threats to eﬃcacy of antimalarials used
for chemoprophylaxis in pregnancy in Nigeria, it would
have been proper for the authors to ascertain the use of
antimalarials by their patients through assay of blood levels
of the drugs. This may be a better way to eliminate the
inﬂuence of antimalarial drugs on the level of parasitaemia
observedintheirstudyratherthanrelyingonthemedication
history of the patients.
The inclusion criteria used in the study appear not to be
clearly deﬁned by the authors. We are not sure if pregnant2 Infectious Diseases in Obstetrics and Gynecology
women with HIV infection and unbooked patients were part
of the cohorts they studied. Perhaps, it would have been
proper to exclude these groups of patients because of the
possible bias their inclusion may introduce into the study
and this may be better avoided by recruiting patients from
antenatal clinics and followed to the time of delivery rather
than recruiting at the point of delivery. HIV and malaria
coinfection has more adverse eﬀects on pregnancy than
malaria alone [9]. The prevalence and intensity of malaria
infection during pregnancy are higher among HIV-infected
women and so is the risk to the woman and her newborn,
irrespective of her gravidity [10]. Coinfection more than
doubled the risk of moderate to severe anaemia in all preg-
nant women [11], meaning that a considerable proportion
of children born to mothers with both HIV and malaria are
more likely to be at risk of low birth weight and infantile
mortality. Unbooked patients are likely to receive antenatal
care from traditional birth attendants, primary health care
centres, or private practitioners who are not knowledgeable
about prevention and control of malaria in pregnancy [12,
13]. Therefore, malaria parasitaemia is likely to be more
prevalent at delivery in unbooked than booked patients.
Mokuolu et al. found a signiﬁcant association between
malaria parasitaemia at delivery and maternal age less than
twenty years. It may be true that pregnancy associated with
acquired immunity is lower in younger women than older
ones who have obtained adequate immunity from repeated
exposures to malaria infections. Teenage pregnancies are
likely to be associated with poverty, lack of good education,
and poor nutrition. The necessary proteins needed in
the synthesis of antibodies against malaria parasites may
therefore be reduced in young pregnant women and may
indirectly contribute to the high prevalence of malaria
parasitaemia observed by the authors in young parturients.
Given that the authors are from various disciplines, a
future study that will involve a multidisciplinary approach is
therefore suggested. The ability of the contributing authors,
who are clinical pharmacologists, to assay blood levels of
antimalarialdrugsinpregnancywilladdnoveltytothefuture
study.
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